Drug Shortage Report for CASPOFUNGIN FOR INJECTION
Report ID | 212553 |
Drug Identification Number | 02460955 |
Brand name | CASPOFUNGIN FOR INJECTION |
Common or Proper name | CASPOFUNGIN FOR INJECTION |
Company Name | JUNO PHARMACEUTICALS CORP. |
Market Status | MARKETED |
Active Ingredient(s) | CASPOFUNGIN |
Strength(s) | 70MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 X 70 MG |
ATC code | J02AX |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-12-06 |
Actual start date | 2023-12-06 |
Estimated end date | 2024-01-31 |
Actual end date | 2024-01-17 |
Shortage status | Resolved |
Updated date | 2024-01-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2233 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 2X7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-01-18 | English | Compare |
v5 | 2024-01-17 | French | Compare |
v4 | 2024-01-17 | English | Compare |
v3 | 2023-12-07 | English | Compare |
v2 | 2023-12-05 | French | Compare |
v1 | 2023-12-05 | English | Compare |
Showing 1 to 6 of 6